Literature DB >> 1518075

Serum interleukin 6 levels become elevated in acute myocardial infarction.

U Ikeda1, F Ohkawa, Y Seino, K Yamamoto, Y Hidaka, T Kasahara, T Kawai, K Shimada.   

Abstract

We have examined serum interleukin 6 (IL-6) levels in 12 patients with acute myocardial infarction (AMI). IL-6 levels became elevated in all patients, following the rise of serum creatine kinase (CK) activity. Peak IL-6 levels showed a good correlation with peak serum C-reactive protein (CRP) levels, while there was no direct relationship between peak IL-6 levels and peak CK activity. IL-6 mRNA was not detected in unstimulated "quiescent" rat cardiocytes cultured in serum-free medium, but its expression was induced by exposure of the cells to serum or ionomycin. These results show that IL-6 is synthesized in the myocardium and serum IL-6 levels become elevated in AMI, suggesting that IL-6 could affect the progression and/or healing processes of AMI.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1518075     DOI: 10.1016/0022-2828(92)91042-4

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  30 in total

1.  Circulating interleukin-6 significantly correlates to thyroid hormone in acute myocardial infarction but not in chronic heart failure.

Authors:  M Nishino; T Kimura; T Kanda; N Kotajima; A Yoshida; A Kuwabara; K Tamama; Y Fukumura; I Kobayashi
Journal:  J Endocrinol Invest       Date:  2000-09       Impact factor: 4.256

2.  Plasma levels of procalcitonin and interleukin-6 in acute myocardial infarction.

Authors:  T Buratti; G Ricevuti; C Pechlaner; M Joannidis; F J Wiedermann; D Gritti; M Herold; C J Wiedermann
Journal:  Inflammation       Date:  2001-04       Impact factor: 4.092

3.  Coenzyme Q10 protects against acute consequences of experimental myocardial infarction in rats.

Authors:  Samy M Eleawa; Mahmoud Alkhateeb; Sanjoy Ghosh; Fahaid Al-Hashem; Abdullah S Shatoor; Abdulmohsen Alhejaily; Mohammad A Khalil
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2015-03-20

Review 4.  Interactions between cytokines and neurohormonal systems in the failing heart.

Authors:  H Kan; M S Finkel
Journal:  Heart Fail Rev       Date:  2001-03       Impact factor: 4.214

5.  Association of TNFSF8 polymorphisms with peripheral neutrophil count.

Authors:  Adelaide M Arruda-Olson; Véronique L Roger; High S Chai; Mariza de Andrade; Brooke L Fridley; Julie M Cunningham; Sherine E Gabriel; Suzette J Bielinski
Journal:  Mayo Clin Proc       Date:  2011-11       Impact factor: 7.616

Review 6.  Apoptosis and oncosis in acute coronary syndromes: assessment and implications.

Authors:  Bodh I Jugdutt; Halliday A Idikio
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

7.  Tissue distribution of angiotensinogen mRNA during experimental inflammation.

Authors:  C Klett; W Hellmann; D Ganten; E Hackenthal
Journal:  Inflammation       Date:  1993-04       Impact factor: 4.092

8.  Methylprednisolone inhibits increase of interleukin 8 and 6 during open heart surgery.

Authors:  T Kawamura; K Inada; H Okada; K Okada; R Wakusawa
Journal:  Can J Anaesth       Date:  1995-05       Impact factor: 5.063

9.  Relation of circulating interleukin-6 to left ventricular remodeling in patients with reperfused anterior myocardial infarction.

Authors:  Tomoaki Ohtsuka; Mareomi Hamada; Katsuji Inoue; Kiyotaka Ohshima; Jun Sujzuki; Tsuyoshi Matsunaka; Akiyoshi Ogimoto; Yuji Hara; Yuji Shigematsu; Jitsuo Higaki
Journal:  Clin Cardiol       Date:  2004-07       Impact factor: 2.882

Review 10.  The varying faces of IL-6: From cardiac protection to cardiac failure.

Authors:  Jillian A Fontes; Noel R Rose; Daniela Čiháková
Journal:  Cytokine       Date:  2015-01-31       Impact factor: 3.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.